• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.

作者信息

Zalaudek Iris, Corneli Paola, Vernoni Sibil, Fedele Dahlia, Papa Giovanni, Conforti Claudio, Retrosi Chiara, Vezzoni Roberta, Fagotti Serena, Longone Michela, Farinazzo Eleonora, di Meo Nicola, Pizzichetta Maria A

机构信息

Skin Cancer Unit, Department of Dermatology, University Hospital of Trieste, Trieste, Italy.

Skin Cancer Unit, Department of Medical Oncology, Maggiore Hospital of Trieste, Trieste, Italy.

出版信息

Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21.

DOI:10.1111/dth.13107
PMID:31595596
Abstract
摘要

相似文献

1
Patterns of response and acquired resistance to the programmed death-1 inhibitor pembrolizumab in Stage III metastatic cutaneous squamous cell carcinoma.III期转移性皮肤鳞状细胞癌对程序性死亡-1抑制剂帕博利珠单抗的反应模式及获得性耐药
Dermatol Ther. 2019 Nov;32(6):e13107. doi: 10.1111/dth.13107. Epub 2019 Oct 21.
2
A Case Report of Unresectable Cutaneous Squamous Cell Carcinoma Responsive to Pembrolizumab, a Programmed Cell Death Protein 1 Inhibitor.一例对程序性细胞死亡蛋白1抑制剂帕博利珠单抗敏感的不可切除皮肤鳞状细胞癌病例报告
JAMA Dermatol. 2016 Jan;152(1):106-8. doi: 10.1001/jamadermatol.2015.2705.
3
Prolonged Response to Pembrolizumab in Spindle Cell Squamous Cell Carcinoma Metastatic to the Central Nervous System.帕博利珠单抗对中枢神经系统转移的梭形细胞鳞状细胞癌的持久反应。
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619850216. doi: 10.1177/2324709619850216.
4
Follow-up on Programmed Cell Death 1 Inhibitor for Cutaneous Squamous Cell Carcinoma.程序性细胞死亡蛋白1抑制剂治疗皮肤鳞状细胞癌的随访
JAMA Dermatol. 2017 Jan 1;153(1):92-94. doi: 10.1001/jamadermatol.2016.3884.
5
Pembrolizumab-associated pyoderma gangrenosum in a patient with metastatic squamous cell carcinoma.帕博利珠单抗相关坏疽性脓皮病在转移性鳞状细胞癌患者中的应用。
Dermatol Online J. 2021 Apr 15;27(4):13030/qt4hs6n388.
6
Multiple keratin granulomata: A potential histologic clue to cutaneous squamous cell carcinoma responding to programmed cell death protein 1 inhibitor therapy.多发性角质形成细胞肉芽肿：皮肤鳞状细胞癌对程序性细胞死亡蛋白1抑制剂治疗有反应的潜在组织学线索。
J Cutan Pathol. 2019 Jun;46(6):452-454. doi: 10.1111/cup.13447. Epub 2019 Apr 4.
7
Rapid response of metastatic cutaneous squamous cell carcinoma to pembrolizumab in a patient with xeroderma pigmentosum: Case report and review of the literature.一名着色性干皮病患者的转移性皮肤鳞状细胞癌对派姆单抗的快速反应：病例报告及文献复习
Eur J Cancer. 2017 Sep;83:99-102. doi: 10.1016/j.ejca.2017.06.022. Epub 2017 Jul 19.
8
PD-1 blockade in patients with advanced cutaneous squamous-cell carcinoma and concurrent chronic lymphocytic leukaemia : a case series and literature review.晚期皮肤鳞状细胞癌合并慢性淋巴细胞白血病患者的程序性死亡受体1阻断治疗：病例系列及文献综述
Eur J Dermatol. 2020 Feb 1;30(1):69-71. doi: 10.1684/ejd.2020.3710.
9
Anti-programmed cell death-1 therapy in nonmelanoma skin cancer.非黑色素瘤皮肤癌中的抗程序性细胞死亡-1疗法。
Br J Dermatol. 2017 Feb;176(2):498-502. doi: 10.1111/bjd.14664. Epub 2016 Oct 17.
10
Rescue therapy with anti-programmed cell death protein 1 inhibitors of advanced cutaneous squamous cell carcinoma and basosquamous carcinoma: preliminary experience in five cases.抗程序性细胞死亡蛋白1抑制剂用于晚期皮肤鳞状细胞癌和基底鳞状细胞癌的挽救治疗：5例初步经验
Br J Dermatol. 2016 Dec;175(6):1382-1386. doi: 10.1111/bjd.14642. Epub 2016 Oct 17.

引用本文的文献

1
Identifying Candidates for Immunotherapy among Patients with Non-Melanoma Skin Cancer: A Review of the Potential Predictors of Response.非黑色素瘤皮肤癌患者中免疫治疗候选者的识别：反应潜在预测因素综述
J Clin Med. 2022 Jun 11;11(12):3364. doi: 10.3390/jcm11123364.